[Erythroderma caused by carbamazepine].
D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014277:Trigeminal Neuralgia / Q000188:drug therapy
D002220:Carbamazepine
Erythrodermie à la carbamazépine.